. 2021 May;22(5):1567–1572. doi: 10.31557/APJCP.2021.22.5.1567

Table 3.

Fold Change for Expression of miRNA92A and miRNA 638 as Well as miRNA92a/ miRNA 638 Ratio of Children with ALL versus Control Children

Groups/ Parameter	GII (Newly diagnosed) n=32	GIII (Remitted) n=18	GIV (Relapsed) n=21
miRNA92a	17.89±7.9	7.13 ±0.93^a,b	14.72±3.8^a
miRNA638	10.19±4.11	4.54 ±1.69^a,b	7.32±1.25^a
Ratio miRNA92a/638	1.75 ±0.64	1.57 ±0.56^a,b	2.01 ±0.77^a

Data are expressed as mean fold change ± SD. ^a, significant p value versus newly diagnosed group; ^b, p value versus relapsed group.